No description available.

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior / As leishmanioses são um grupo de doenças causadas por protozoários do gênero Leishmania spp que afetam 98 países. No Brasil, no ano de 2013, foram relatados 3.253 casos de leishmaniose visceral e 18.226 casos de Leishmaniose Tegumentar Americana. O tratamento de primeira escolha continua sendo realizado com antimoniais pentavalentes, e em casos de insucessos os fármacos de segunda escolha são a pentamidina e a anfotericina B. Tais medicamentos causam intensos efeitos adversos e ultimamente têm surgido cepas resistentes aos mesmos. Em áreas endêmicas têm sido cada vez mais comum o surgimento da co-infecção Leishmania com Mycobacterium tuberculosis. O tratamento para a tuberculose com pirazinamida (PZA) e isoniazida (INZ), controla a leishmaniose. Esses dados sugerem atividade anti-leishmania da PZA e da INZ. O objetivo deste trabalho foi avaliar a atividade in vitro da INZ e da PZA e seus compostos derivados (série G e série R, respectivamente) sobre Leishmania (Viannia) braziliensis. As moléculas foram testadas em monocamadas de macrófagos peritoneais de camunongos infectados com L. (V) braziliensis durante 48h. Todas as moléculas testadas inibiram o índice de infecção de forma dose dependente em comparação aos controles. As moléculas da série R foram mais ativas do que a PZA, porém o resultado foi significativo somente para a R02 (p < 0,005). Apenas a molécula R05 (76,64M) foi relativamente tóxica para macrófagos. Os compostos mais ativos foram R02, G01 e G02, cujos índices de seletividade foram 14,31, 19 e 30, respectivamente. A dosagem de nitrito foi feita em sobrenadantes de monocamadas de macrófagos peritoniais infectados e tratados com as substâncias nas concentrações 10 e 100M. A G01 e a G02 estimularam a produção de NO2 nas duas concentrações, entretanto o resultado foi estatisticamente significativo para a G02 em 100M (p < 0,0001), a G05 só estimulou óxido nítrico na maior concentração. Todos os compostos da série R estimularam NO2, contudo, o resultado foi estatisticamente significativo para a R03 e R05 a 100M (p < 0,001). Adicionalmente, foi realizado uma análise preditiva in sílico de parâmetros farmacocinéticos das moléculas mais ativas in vitro, utilizando o software admetSAR. Os dados obtidos mostraram que de forma semelhante às suas moléculas originais a G01, G02 e R02 apresentaram alta capacidade de serem absorvidas pelo trato gastrointestinal, baixo potencial hepatotoxico e carcinogênico. Juntos, esses dados demonstram que essas moléculas são seletivamente tóxicas para o parasito com potencial para serem testadas pela via oral em estudos em modelo experimental de infecção. / Leishmaniasis are a group of diseases caused by protozoan of genus Leishmania spp affecting of 98 countries. In Brazil, in the year 2013 were 3.253 reported cases of visceral leishmaniasis and 18.226 cases of cutaneous leishmaniasis. The first choice of treatment is still performed with pentavalent antimonials and in cases of failures drugs of second line of treatment are pentamidine and anfotericin B. These drugs cause many adverse effects and has lately emerged resistant strains. In endemic areas it has been increasingly common the appearance of co-infection Leishmania and Mycobacterium tuberculosis. The treatment of tuberculosis with pyrazinamid and isoniazid control the leishmaniasis.The aim of this study was evaluate the anti-leishmania activity in vitro of INZ and PZA and yours derivatives compounds (serie G and serie R,respectively) on the Leishmania (Viannia) braziliensis. The molecules were tested on infected monolayers of peritoneal murine macrophages for 48h. All the molecules te inhibited the infection index in a dose-dependent manner in relation to controls. The molecules of the R series were more active than PZA, but the result was only significant for R02 (p < 0,005). Only R05 (CC50 = 76,64M) was relatively toxic to macrophages. The most active compounds were R02, G01 and G02 whose select index were 14,31, 19 and 30, respectively. Nitrite assay was performed in supernatants of infected monolayers of peritonial macrophages treated with the substancies at 10 and 100M. G01 and G02 stimulated NO2 prodution, however, the result was only statistically significant for G02 at 100M (p < 0,001). All the compounds of R serie stimulated NO2 production however the results were statistically significant for the R03 and R05 at 100M (p < 0,001). Additionally, a in silico preditive pharmacokinetic analysis was performed to active molecules using the admetSAR software the data showed that G01, G02 and R02 were similar to their original molecules as to high capacity to be absorbed by the gastrointestinal tract, low hepatotoxic and carcinogenic potencial. Together, these data demonstrate that these molecules are selectively toxic to the parasite with the potencial to be tested orally on studies in experimental infection.

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior / As leishmanioses são um grupo de doenças causadas por protozoários do gênero Leishmania spp que afetam 98 países. No Brasil, no ano de 2013, foram relatados 3.253 casos de leishmaniose visceral e 18.226 casos de Leishmaniose Tegumentar Americana. O tratamento de primeira escolha continua sendo realizado com antimoniais pentavalentes, e em casos de insucessos os fármacos de segunda escolha são a pentamidina e a anfotericina B. Tais medicamentos causam intensos efeitos adversos e ultimamente têm surgido cepas resistentes aos mesmos. Em áreas endêmicas têm sido cada vez mais comum o surgimento da co-infecção Leishmania com Mycobacterium tuberculosis. O tratamento para a tuberculose com pirazinamida (PZA) e isoniazida (INZ), controla a leishmaniose. Esses dados sugerem atividade anti-leishmania da PZA e da INZ. O objetivo deste trabalho foi avaliar a atividade in vitro da INZ e da PZA e seus compostos derivados (série G e série R, respectivamente) sobre Leishmania (Viannia) braziliensis. As moléculas foram testadas em monocamadas de macrófagos peritoneais de camunongos infectados com L. (V) braziliensis durante 48h. Todas as moléculas testadas inibiram o índice de infecção de forma dose dependente em comparação aos controles. As moléculas da série R foram mais ativas do que a PZA, porém o resultado foi significativo somente para a R02 (p < 0,005). Apenas a molécula R05 (76,64M) foi relativamente tóxica para macrófagos. Os compostos mais ativos foram R02, G01 e G02, cujos índices de seletividade foram 14,31, 19 e 30, respectivamente. A dosagem de nitrito foi feita em sobrenadantes de monocamadas de macrófagos peritoniais infectados e tratados com as substâncias nas concentrações 10 e 100M. A G01 e a G02 estimularam a produção de NO2 nas duas concentrações, entretanto o resultado foi estatisticamente significativo para a G02 em 100M (p < 0,0001), a G05 só estimulou óxido nítrico na maior concentração. Todos os compostos da série R estimularam NO2, contudo, o resultado foi estatisticamente significativo para a R03 e R05 a 100M (p < 0,001). Adicionalmente, foi realizado uma análise preditiva in sílico de parâmetros farmacocinéticos das moléculas mais ativas in vitro, utilizando o software admetSAR. Os dados obtidos mostraram que de forma semelhante às suas moléculas originais a G01, G02 e R02 apresentaram alta capacidade de serem absorvidas pelo trato gastrointestinal, baixo potencial hepatotoxico e carcinogênico. Juntos, esses dados demonstram que essas moléculas são seletivamente tóxicas para o parasito com potencial para serem testadas pela via oral em estudos em modelo experimental de infecção. / Leishmaniasis are a group of diseases caused by protozoan of genus Leishmania spp affecting of 98 countries. In Brazil, in the year 2013 were 3.253 reported cases of visceral leishmaniasis and 18.226 cases of cutaneous leishmaniasis. The first choice of treatment is still performed with pentavalent antimonials and in cases of failures drugs of second line of treatment are pentamidine and anfotericin B. These drugs cause many adverse effects and has lately emerged resistant strains. In endemic areas it has been increasingly common the appearance of co-infection Leishmania and Mycobacterium tuberculosis. The treatment of tuberculosis with pyrazinamid and isoniazid control the leishmaniasis.The aim of this study was evaluate the anti-leishmania activity in vitro of INZ and PZA and yours derivatives compounds (serie G and serie R,respectively) on the Leishmania (Viannia) braziliensis. The molecules were tested on infected monolayers of peritoneal murine macrophages for 48h. All the molecules te inhibited the infection index in a dose-dependent manner in relation to controls. The molecules of the R series were more active than PZA, but the result was only significant for R02 (p < 0,005). Only R05 (CC50 = 76,64M) was relatively toxic to macrophages. The most active compounds were R02, G01 and G02 whose select index were 14,31, 19 and 30, respectively. Nitrite assay was performed in supernatants of infected monolayers of peritonial macrophages treated with the substancies at 10 and 100M. G01 and G02 stimulated NO2 prodution, however, the result was only statistically significant for G02 at 100M (p < 0,001). All the compounds of R serie stimulated NO2 production however the results were statistically significant for the R03 and R05 at 100M (p < 0,001). Additionally, a in silico preditive pharmacokinetic analysis was performed to active molecules using the admetSAR software the data showed that G01, G02 and R02 were similar to their original molecules as to high capacity to be absorbed by the gastrointestinal tract, low hepatotoxic and carcinogenic potencial. Together, these data demonstrate that these molecules are selectively toxic to the parasite with the potencial to be tested orally on studies in experimental infection.

A buva (Conyza spp.) é uma planta daninha anual, comum em lavouras de soja da região Sul do Brasil, onde os herbicidas chlorimuron-ethyl e glyphosate são os mais utilizados para o seu controle. No entanto, nas últimas safras de soja observou-se controle insatisfatório desta planta daninha com esses herbicidas. Esse fato gerou a suspeita de seleção de biótipos resistentes. Assim, o objetivo da pesquisa foi avaliar a ocorrência de resistência múltipla aos herbicidas chlorimuron-ethyl e glyphosate em biótipos de buva. Na primeira etapa do trabalho, foram feitas coletas de sementes de buva em áreas com controle insatisfatório, totalizando 25 biótipos. Esses biótipos foram avaliados com relação à suscetibilidade e resistência ao chlorimuron e glyphosate, aplicando-se a máxima dose de registro desses herbicidas. Para segunda etapa do trabalho, foram selecionados 5 biótipos de buva com grau de suscetibilidade contrastante. Esses biótipos foram avaliados com curvas de dose-resposta e com 5 doses do herbicida chlorimuron-ethyl, aplicadas no estádio fenológico de 3 a 4 folhas. Na terceira etapa do trabalho, foi avaliada a resposta de 4 biótipos de buva aos herbicidas chlorimuron-ethyl, glyphosate e associação de chlorimuron-ethyl e glyphosate. Os herbicidas foram empregados em oito doses: 0,0; 6,25; 12,5; 25; 50; 100; 200 e 400, representadas em porcentagem da dose de 20 g ha-1 chlorimuron-ethyl, e de 720 g e.a. ha-1 glyphosate, aplicadas em três estádios de desenvolvimento (altura 0,5 a 1 cm e/ou 3 a 4 folhas; altura 1 a 2 cm e/ou 6 a 7 folhas e; altura 10 a 12 cm e/ou 12 a 14 folhas) dos biótipos de buva. Na última etapa do trabalho, avaliaram-se 15 herbicidas para controle alternativo da buva no estádio de desenvolvimento de 5 a 7 cm de altura e/ou 7 a 8 folhas. O trabalho foi conduzido na casa de vegetação, da Estação Experimental da Embrapa Trigo, em Passo Fundo/RS. Os resultados evidenciam que todos os biótipos são controlados com a dose de 20 g ha-1 de chlorimuronethyl, no estádio de desenvolvimento de 3 a 4 folhas. Contudo, observou-se susceptibilidade diferencial entre os biótipos em doses menores que 20 g ha-1 indicando resistência de nível baixo. Também, ficou evidente que os estádios de desenvolvimento dos biótipos de buva afetam significativamente a resposta destes aos herbicidas, sendo que quanto mais avançado o estádio menor a sensibilidade. A exceção foi o biótipo 5 que demonstrou resistência ao glyphosate, independentemente do estádio de desenvolvimento. Por fim, os tratamentos alternativos 2,4-D (1.042 g ha-1); amonium glufosinate (400 g ha-1); glyphosate (900 g e.a. ha- 1) + 2,4-D (1.042 g ha-1); glyphosate (900 g e.a ha-1) + amonium glufosinate (400 g ha-1); paraquat (600 g ha-1) + diuron (300 g ha-1); tembotrione (84 g ha-1) e tembotrione (84 g ha-1) + atrazine (1.000 g ha-1) controlaram, eficientemente, os biótipos de buva avaliados. Como conclusão, indica-se a aplicação do herbicida chlorimuron-ethyl nas doses máximas registradas, em estádios de desenvolvimentos da buva inferiores a cinco folhas, e que a prática de rotação de mecanismos de ação seja usada no manejo químico dessas áreas. / The horseweed (Conyza spp.) is an annual weed, common in soybean crops in southern Brazil, where the herbicide chlorimuron-ethyl and glyphosate are the most commonly used for its control. However, in recent soybean harvests it was observed unsatisfactory control of this weed with these herbicides. This fact originated suspicion of selection of resistant biotypes. The objective of the research was to evaluate the occurrence of multiple resistances to herbicides chlorimuron-ethyl and glyphosate in horseweed biotypes. In the first stage of the research, were collected horseweed seeds in areas with unsatisfactory control, totaling 25 biotypes. These biotypes were assessed for susceptibility and resistance to chlorimuron and glyphosate, applying the maximum dose of herbicide registration. In the second stage, were selected 5 horseweed biotypes with contrasting degree of susceptibility and evaluated dose-response curves, with 5 doses of the herbicide chlorimuron-ethyl applied at growth stage 3 - 4 leaves. In the third stage, we evaluated the response of four biotypes of horseweed to the herbicide chlorimuron-ethyl, glyphosate and association of chlorimuronethyl and glyphosate. Herbicides were applied in eight doses: 0.0, 6.25, 12.5, 25, 50, 100, 200 and 400, represented as a percentage of the dose of 20 g ha-1 chlorimuron-ethyl, and 720 g a.e. ha-1 glyphosate applied at three stages of development (height 0.5 - 1 cm and / or 3 - 4 leaves, height 1 - 2 cm, and / or 6 - 7 and leaves, height 10 - 12 cm and / or 12 - 14 leaves) biotypes of horseweed. In the last stage of the study, evaluated 15 alternative herbicides to control horseweed at stage 5 - 7 cm high and / or 7 - 8 leaves. The study was conducted in a greenhouse, at the Experimental Station of Embrapa Trigo, Passo Fundo / RS. The results show that all biotypes can be controlled with the dose of 20 g ha-1 chlorimuron-ethyl, at stage 3 - 4 leaves. However, it was observed differential susceptibility among biotypes at doses under than 20 g ha-1 indicating low resistance. It was also evident that the developmental stages of the biotypes of horseweed, significantly affect the response to these herbicides, whereas the more advanced the stage the lower sensitivity. The exception was the biotype 5 that show resistance to glyphosate, regardless of the stage of development. Finally, alternative treatments 2,4-D (1.042 g ha-1); ammonium glufosinate (400 g ha-1), glyphosate (900 g a.e. ha- 1) + 2,4-D (1.042 g ha-1), glyphosate (900 g a.e. ha-1) + ammonium glufosinate (400 g ha-1), paraquat (600 g ha-1) + diuron (300 g ha-1); tembotrione (84 g ha-1) and tembotrione (84 g ha- 1) + atrazine (1,000 g ha-1), effectively controlled the biotypes of horseweed evaluated. Conclusion indicates the application of herbicide chlorimuron-ethyl in maximum doses recorded in stadiums horseweed developments less than five leaves, and that the practice of rotating mechanisms of action are used in the chemical management of these areas.

A buva (Conyza spp.) é uma planta daninha anual, comum em lavouras de soja da região Sul do Brasil, onde os herbicidas chlorimuron-ethyl e glyphosate são os mais utilizados para o seu controle. No entanto, nas últimas safras de soja observou-se controle insatisfatório desta planta daninha com esses herbicidas. Esse fato gerou a suspeita de seleção de biótipos resistentes. Assim, o objetivo da pesquisa foi avaliar a ocorrência de resistência múltipla aos herbicidas chlorimuron-ethyl e glyphosate em biótipos de buva. Na primeira etapa do trabalho, foram feitas coletas de sementes de buva em áreas com controle insatisfatório, totalizando 25 biótipos. Esses biótipos foram avaliados com relação à suscetibilidade e resistência ao chlorimuron e glyphosate, aplicando-se a máxima dose de registro desses herbicidas. Para segunda etapa do trabalho, foram selecionados 5 biótipos de buva com grau de suscetibilidade contrastante. Esses biótipos foram avaliados com curvas de dose-resposta e com 5 doses do herbicida chlorimuron-ethyl, aplicadas no estádio fenológico de 3 a 4 folhas. Na terceira etapa do trabalho, foi avaliada a resposta de 4 biótipos de buva aos herbicidas chlorimuron-ethyl, glyphosate e associação de chlorimuron-ethyl e glyphosate. Os herbicidas foram empregados em oito doses: 0,0; 6,25; 12,5; 25; 50; 100; 200 e 400, representadas em porcentagem da dose de 20 g ha-1 chlorimuron-ethyl, e de 720 g e.a. ha-1 glyphosate, aplicadas em três estádios de desenvolvimento (altura 0,5 a 1 cm e/ou 3 a 4 folhas; altura 1 a 2 cm e/ou 6 a 7 folhas e; altura 10 a 12 cm e/ou 12 a 14 folhas) dos biótipos de buva. Na última etapa do trabalho, avaliaram-se 15 herbicidas para controle alternativo da buva no estádio de desenvolvimento de 5 a 7 cm de altura e/ou 7 a 8 folhas. O trabalho foi conduzido na casa de vegetação, da Estação Experimental da Embrapa Trigo, em Passo Fundo/RS. Os resultados evidenciam que todos os biótipos são controlados com a dose de 20 g ha-1 de chlorimuronethyl, no estádio de desenvolvimento de 3 a 4 folhas. Contudo, observou-se susceptibilidade diferencial entre os biótipos em doses menores que 20 g ha-1 indicando resistência de nível baixo. Também, ficou evidente que os estádios de desenvolvimento dos biótipos de buva afetam significativamente a resposta destes aos herbicidas, sendo que quanto mais avançado o estádio menor a sensibilidade. A exceção foi o biótipo 5 que demonstrou resistência ao glyphosate, independentemente do estádio de desenvolvimento. Por fim, os tratamentos alternativos 2,4-D (1.042 g ha-1); amonium glufosinate (400 g ha-1); glyphosate (900 g e.a. ha- 1) + 2,4-D (1.042 g ha-1); glyphosate (900 g e.a ha-1) + amonium glufosinate (400 g ha-1); paraquat (600 g ha-1) + diuron (300 g ha-1); tembotrione (84 g ha-1) e tembotrione (84 g ha-1) + atrazine (1.000 g ha-1) controlaram, eficientemente, os biótipos de buva avaliados. Como conclusão, indica-se a aplicação do herbicida chlorimuron-ethyl nas doses máximas registradas, em estádios de desenvolvimentos da buva inferiores a cinco folhas, e que a prática de rotação de mecanismos de ação seja usada no manejo químico dessas áreas. / The horseweed (Conyza spp.) is an annual weed, common in soybean crops in southern Brazil, where the herbicide chlorimuron-ethyl and glyphosate are the most commonly used for its control. However, in recent soybean harvests it was observed unsatisfactory control of this weed with these herbicides. This fact originated suspicion of selection of resistant biotypes. The objective of the research was to evaluate the occurrence of multiple resistances to herbicides chlorimuron-ethyl and glyphosate in horseweed biotypes. In the first stage of the research, were collected horseweed seeds in areas with unsatisfactory control, totaling 25 biotypes. These biotypes were assessed for susceptibility and resistance to chlorimuron and glyphosate, applying the maximum dose of herbicide registration. In the second stage, were selected 5 horseweed biotypes with contrasting degree of susceptibility and evaluated dose-response curves, with 5 doses of the herbicide chlorimuron-ethyl applied at growth stage 3 - 4 leaves. In the third stage, we evaluated the response of four biotypes of horseweed to the herbicide chlorimuron-ethyl, glyphosate and association of chlorimuronethyl and glyphosate. Herbicides were applied in eight doses: 0.0, 6.25, 12.5, 25, 50, 100, 200 and 400, represented as a percentage of the dose of 20 g ha-1 chlorimuron-ethyl, and 720 g a.e. ha-1 glyphosate applied at three stages of development (height 0.5 - 1 cm and / or 3 - 4 leaves, height 1 - 2 cm, and / or 6 - 7 and leaves, height 10 - 12 cm and / or 12 - 14 leaves) biotypes of horseweed. In the last stage of the study, evaluated 15 alternative herbicides to control horseweed at stage 5 - 7 cm high and / or 7 - 8 leaves. The study was conducted in a greenhouse, at the Experimental Station of Embrapa Trigo, Passo Fundo / RS. The results show that all biotypes can be controlled with the dose of 20 g ha-1 chlorimuron-ethyl, at stage 3 - 4 leaves. However, it was observed differential susceptibility among biotypes at doses under than 20 g ha-1 indicating low resistance. It was also evident that the developmental stages of the biotypes of horseweed, significantly affect the response to these herbicides, whereas the more advanced the stage the lower sensitivity. The exception was the biotype 5 that show resistance to glyphosate, regardless of the stage of development. Finally, alternative treatments 2,4-D (1.042 g ha-1); ammonium glufosinate (400 g ha-1), glyphosate (900 g a.e. ha- 1) + 2,4-D (1.042 g ha-1), glyphosate (900 g a.e. ha-1) + ammonium glufosinate (400 g ha-1), paraquat (600 g ha-1) + diuron (300 g ha-1); tembotrione (84 g ha-1) and tembotrione (84 g ha- 1) + atrazine (1,000 g ha-1), effectively controlled the biotypes of horseweed evaluated. Conclusion indicates the application of herbicide chlorimuron-ethyl in maximum doses recorded in stadiums horseweed developments less than five leaves, and that the practice of rotating mechanisms of action are used in the chemical management of these areas.

L'ingénierie enzymatique est un outil très avantageux dans l'industrie biotechnologique. Elle permet d'adapter les enzymes à une activité ou à une condition de réaction spécifique. En outre, elle peut permettre de déchiffrer les éléments clés qui ont facilité leur modification. Bien que l'ingénierie enzymatique soit largement pratiquée, elle comporte encore plusieurs goulets d'étranglement. Certains de ces goulets d'étranglement sont techniques, comme le développement de méthodologies pour la création de banques de mutations ciblées ou la réalisation de criblages à haut débit, et d'autres sont conceptuels, comme le déchiffrage des caractéristiques clés pertinentes d'une protéine cible pour la réussite d'un projet d'ingénierie. Parmi ces défis, l'épistasie intra-génique, ou la non-additivité des effets phénotypiques des mutations, est une caractéristique qui entrave grandement la prévisibilité. L'amélioration de l'ingénierie enzymatique nécessite une approche multidisciplinaire qui inclut une meilleure compréhension des relations structure-fonction-évolution. Cette thèse vise à contribuer à l'avancement de l'ingénierie enzymatique en étudiant deux systèmes modèles. Premièrement, des variantes dynamiques de la ß-lactamase TEM-1 ont été choisies pour étudier le lien entre la dynamique des protéines et l'évolution. La ß-lactamase TEM-1 a été largement caractérisée dans la littérature, ce qui s'est traduit par des connaissances approfondies sur son mécanisme de réaction, ses caractéristiques structurelles et son évolution. Les variantes de la ß-lactamase TEM-1 utilisées comme système modèle dans cette thèse ont été largement caractérisées, montrant une dynamique accrue à l'échelle temporelle pertinente pour la catalyse (µs à ms) mais maintenant la reconnaissance du substrat. Dans cette thèse, l'évolution in vitro de ces variantes dynamiques a été réalisée par des cycles itératifs de mutagenèse et de sélection aléatoires pour permettre une exploration impartiale du paysage de ‘fitness’. Nous démontrons que la présence de ces mouvements particuliers au début de l'évolution a permis d'accéder à des voies de mutations connues. De plus, des interactions épistatiques connues ont été introduites dans les variantes dynamiques. Leur caractérisation in silico et cinétique a révélé que les mouvements supplémentaires sur l'échelle de temps de la catalyse ont permis d'accéder à des conformations conduisant à une fonction améliorée, comme dans le TEM-1 natif. Dans l'ensemble, nous démontrons que l'évolution de la b-lactamase TEM-1 vers une nouvelle fonction est compatible avec divers mouvements à l'échelle de temps µs à ms. Il reste à savoir si cela peut se traduire par d'autres enzymes ayant un potentiel biotechnologique. Deuxièmement, la lipase Cal-A, pertinente sur le plan industriel, a été choisie pour identifier les caractéristiques qui pourraient faciliter son ingénierie. La lipase Cal-A présente des caractéristiques telles que la polyvalence du substrat et une grande stabilité thermique et réactivité qui la rendent attrayante pour la modification des triglycérides ou la synthèse de molécules pertinentes dans les industries alimentaire et pharmaceutique. Contrairement à TEM-1, la plupart des études d'évolution in vitro de la lipase Cal-A ont été réalisées dans un but industriel, avec une exploration limitée de l'espace de mutation. Par conséquent, les caractéristiques qui définissent la fonction de la lipase Cal-A restent insaisissables. Dans cette thèse, nous faisons état de la mutagenèse ciblée de la lipase Cal-A, confirmant l'existence d'une région clé pour la reconnaissance du substrat. Cela a été fait en combinant une nouvelle méthodologie de création de bibliothèque basée sur l'assemblage Golden-gate avec une visualisation structurelle basée sur des scripts pour identifier et cartographier les mutations sélectionnées dans la structure 3D. La caractérisation et la déconvolution de deux des plus aptes ont révélé l'existence d'une épistasie dans l'évolution de la lipase Cal-A vers une nouvelle fonction. Dans l'ensemble, nous démontrons que l’identification d'une variété de propriétés suite à la mutagenèse ciblée peut grandement améliorer la connaissance d'une enzyme. Cette information peut être appliquée pour améliorer l'efficacité de l'ingénierie dirigée. / Enzyme engineering is a tool with great utility in the biotechnological industry. It allows to tailor enzymes to a specific activity or reaction condition. In addition, it can allow to decipher key elements that facilitated their modification. While enzyme engineering is extensively practised, it still entails several bottlenecks. Some of these bottlenecks are technical such as the development of methodologies for creating targeted mutational libraries or performing high-throughput screening and some are conceptual such as deciphering the key relevant features in a target protein for a successful engineering project. Among these challenges, intragenic epistasis, or the non-additivity of the phenotypic effects of mutations, is a feature that greatly hinders predictability. Improving enzyme engineering needs a multidisciplinary approach that includes gaining a better understanding of structure-function-evolution relations. This thesis seeks to contribute in the advancement of enzyme engineering by investigating two model systems. First, dynamic variants of TEM-1 ß-lactamase were chosen to investigate the link between protein dynamics and evolution. TEM-1 ß-lactamase has been extensively characterized in the literature, which has translated into extensive knowledge on its reaction mechanism, structural features and evolution. The variants of TEM-1 ß-lactamase used as model system in this thesis had been extensively characterized, showing increased dynamics at the timescale relevant to catalysis (µs to ms) but maintaining substrate recognition. In this thesis, in vitro evolution of these dynamic variants was done by iterative rounds of random mutagenesis and selection to allow an unbiased exploration of the fitness landscape. We demonstrate that the presence of these particular motions at the outset of evolution allowed access to known mutational pathways. In addition, known epistatic interactions were introduced in the dynamic variants. Their in silico and kinetic characterization revealed that the additional motions on the timescale of catalysis allowed access to conformations leading to enhanced function, as in native TEM-1. Overall, we demonstrate that the evolution of TEM-1 b-lactamase toward new function is compatible with diverse motions at the µs to ms timescale. Whether this can be translated to other enzymes with biotechnological potential remains to be explored. Secondly, the industrially relevant Cal-A lipase was chosen to identify features that could facilitate its engineering. Cal-A lipase presents characteristics such as substrate versatility and high thermal stability and reactivity that make it attractive for modification of triglycerides or synthesis of relevant molecules in the food and pharmaceutical industries. Contrary to TEM-1, most in vitro evolution studies of Cal-A lipase have been done towards an industrially-specified goal, with limited exploration of mutational space. As a result, features that define function in Cal-A lipase remain elusive. In this thesis, we report on focused mutagenesis of Cal-A lipase, confirming the existence of a key region for substrate recognition. This was done by combining a novel library creation methodology based on Golden-gate assembly with script-based structural visualization to identify and map the selected mutations into the 3D structure. The characterization and deconvolution of two of the fittest revealed the existence of epistasis in the evolution of Cal-A lipase towards new function. Overall, we demonstrate that mapping a variety of properties following mutagenesis targeted to specific regions can greatly improve knowledge of an enzyme that can be applied to improve the efficiency of directed engineering.